— Know what they know.
Not Investment Advice

BSGM NASDAQ

BioSig Technologies, Inc.
1W: -0.4% 1M: +24.0% 3M: +5.5% 1Y: +1758.6% 3Y: -17.6% 5Y: -88.8%
$6.10
Last traded 2025-10-09 — delisted
NASDAQ · Healthcare · Medical - Devices · $191.1M mcap · 19M float · 6.04% daily turnover · Short 61% of daily vol

Cash Flow Trends

Operating Cash Flow
-$5M +72.5% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$5M +72.8% ▲
Dividends Paid
$9K +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$48K +71.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$59M-$33M-$27M-$29M-$10M
Depreciation & Amort.$550K$198K$293K$361K$188K
Stock-Based Comp.$25M$10M$4M$8M$7M
Change in Working Capital$2M-$3M$464K$769K$363K
Other Non-Cash Items$4M$441K$388K$2M-$2M
Operating Cash Flow-$27M-$26M-$22M-$17M-$5M
— Investing Activities —
Capital Expenditures-$87K-$542K-$168K-$186K$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$87K-$542K-$168K-$186K$0
— Financing Activities —
Net Debt Issuance$0$0$0$0$500K
Stock Repurchased$0$0$0$0$0
Dividends Paid-$180K-$9K-$9K-$9K-$9K
Other Financing$16M$37K$227K$2M$9K
Financing Cash Flow$43M$10M$11M$17M$5M
Net Change in Cash$16M-$17M-$11M-$167K-$48K
Cash End of Period$28M$12M$357K$190K$142K
Free Cash Flow-$27M-$27M-$22M-$17M-$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms